NASDAQ · INNV
Healthcare · Medical - Care Facilities
$11.03
Down-$0.43 (-3.90%)
Updated Sep 10, 2026, 10:44 PM
SID Score
5.8/10
Composite research score
Smart Money
—
Institutional and insider signal
Price performance
1M range · 20 trading sessions · Daily adjusted prices
INNV closed at $11.03 after 20 trading sessions, up 5.75% for the selected period.
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 9, 2026 | $11.70 | $12.1999 | $10.92 | $11.03 | 924.67K |
| Sep 8, 2026 | $10.68 | $10.68 | $10.23 | $10.52 | 546.75K |
| Sep 4, 2026 | $10.74 | $11.05 | $10.59 | $10.75 | 161.44K |
| Sep 3, 2026 | $10.88 | $10.92 | $10.61 | $10.77 | 122.98K |
| Sep 2, 2026 | $10.89 | $11.23 | $10.69 | $10.81 | 232.44K |
| Sep 1, 2026 | $10.78 | $11.235 | $10.78 | $10.83 | 184.81K |
| Aug 31, 2026 | $10.79 | $10.89 | $10.54 | $10.80 | 249.77K |
| Aug 28, 2026 | $11.05 | $11.05 | $10.75 | $10.86 | 131.76K |
| Aug 27, 2026 | $10.99 | $11.12 | $10.89 | $11.03 | 191.78K |
| Aug 26, 2026 | $10.88 | $11.27 | $10.88 | $11.04 | 143.35K |
| Aug 25, 2026 | $11.04 | $11.24 | $10.806 | $10.92 | 149.46K |
| Aug 24, 2026 | $10.96 | $11.31 | $10.75 | $11.02 | 195.31K |
| Aug 21, 2026 | $11.255 | $11.98 | $10.83 | $10.96 | 366.08K |
| Aug 20, 2026 | $10.85 | $11.10 | $10.59 | $10.72 | 124.27K |
| Aug 19, 2026 | $11.22 | $11.41 | $10.8038 | $10.94 | 158.04K |
| Aug 18, 2026 | $10.64 | $11.13 | $10.64 | $11.10 | 198.92K |
| Aug 17, 2026 | $10.64 | $10.78 | $10.40 | $10.67 | 175.72K |
| Aug 14, 2026 | $10.63 | $10.80 | $10.51 | $10.61 | 213.5K |
| Aug 13, 2026 | $10.53 | $10.79 | $10.37 | $10.65 | 117.66K |
| Aug 12, 2026 | $10.26 | $10.515 | $10.09 | $10.43 | 144.23K |
The latest Smart Investors Daily articles mentioning INNV.
INNV research
Company profile and research snapshot.
InnovAge Holding Corp is a healthcare delivery platform comprising multiple participants focused on providing all-inclusive, capitated care to high-cost seniors, many of whom are dual-eligible. Its programs are designed to address two of the pressing challenges facing the U.S. healthcare industry: rising costs and poor outcomes. The purpose of the participant-centered care delivery approach is to improve the quality of care participants receive, while keeping them in their homes for as long as possible and reducing the overutilization of high-cost care settings, such as hospitals and nursing homes. The company manages its business as one reportable segment, PACE.
Visit company websiteConsensus and target data currently published for this company.
| Date | Firm | Rating | Target |
|---|---|---|---|
| Sep 9, 2026 | Keybanc | Overweight | — |
| Aug 21, 2026 | Keybanc | Overweight | — |
| Feb 23, 2026 | JP Morgan | Underweight | — |
| Dec 17, 2024 | JP Morgan | Underweight | — |
| Oct 11, 2024 | Keybanc | Sector Weight | — |
Generated Sep 10, 2026, 5:12 PM
InnovAge shares fell 4.51% today despite posting a revenue beat in Q4 2026 earnings, as an earnings-per-share miss and modest forward guidance disappointed investors. The company's mixed results highlight the tension between top-line growth and bottom-line profitability challenges.
Bottom line: InnovAge's Q4 earnings reveal a company executing on top-line growth but struggling with profitability, resulting in today's 4.51% decline despite beating revenue estimates. Investors should monitor whether FY2027 results can narrow the gap between strong revenue growth and underwhelming EPS, as the current valuation may not justify holding through near-term margin headwinds.
Yahoo · Sep 9, 2026
Adjusted EBITDA surges 175% in fiscal 2026 as the company outlines a disciplined path to 10%+ margins amid a tempered 2027 rate environment.
Yahoo · Sep 8, 2026
InnovAge (NASDAQ:INNV) reported fiscal 2026 revenue growth, higher census and a sharp increase in adjusted EBITDA as the provider of Program of All-Inclusive Care for the Elderly, or PACE, services said it has moved beyond a multiyear operational turnaround and is focusing on scalable growth. For t
SeekingAlpha · Sep 8, 2026
Yahoo · Sep 8, 2026
InnovAge (INNV) delivered earnings and revenue surprises of -33.33% and +9.90%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
The latest Smart Investors Daily articles mentioning INNV.
